Pat LePore
Chairman chez PAR PHARMACEUTICAL COMPANIES, INC.
Fortune : 115 639 $ au 31/05/2023
Profil
Patrick G.
LePore was the founder of Boron, LePore & Associates, Inc. (founded in 1985) where he served as Chairman, President & Chief Executive Officer from 1996 to 2002.
He currently holds the position of Chairman at Endo Generics Holdings, Inc. since 2007, Chairman at Lautus Pharmaceuticals LLC since 2013, Director at Tyme, Inc. since 2015, Lead Independent Director at VYNE Therapeutics, Inc. since 2020, and Trustee at Villanova University.
In his former positions, Mr. LePore served as Chairman, President & Chief Executive Officer at Par Pharmaceutical, Inc. from 2006 to 2012, Independent Non-Executive Chairman at Lannett Co., Inc. from 2017 to 2023, Chairman at AgeneBio, Inc., Vice Chairman at Matinas BioPharma Holdings, Inc. from 2018 to 2021, Independent Director at Tyme Technologies, Inc., Independent Director at Innoviva, Inc. from 2016 to 2018, Independent Director at PharMerica Corp.
from 2013 to 2017, and President-Healthcare Marketing Group at Cardinal Health, Inc. from 2002 to 2005.
Mr. LePore holds an MBA from Fairleigh Dickinson University and an undergraduate degree from Villanova University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
VYNE THERAPEUTICS INC
0,26% | 01/01/2024 | 36 472 ( 0,26% ) | 111 969 $ | 31/03/2024 |
LANNETT COMPANY, INC.
1,36% | 10/11/2022 | 146 786 ( 1,36% ) | 3 670 $ | 31/05/2023 |
Postes actifs de Pat LePore
| Sociétés | Poste | Début |
|---|---|---|
| PAR PHARMACEUTICAL COMPANIES, INC. | Chairman | - |
| VYNE THERAPEUTICS INC. | Director/Board Member | 10/09/2020 |
| Villanova University | Director/Board Member | - |
Tyme, Inc.
 Tyme, Inc. BiotechnologyHealth Technology Part of Syros Pharmaceuticals, Inc., Tyme, Inc. is a private company that provides research and development services focused on developing drug candidates for the treatment of cancer. The company is based in Wilmington, DE. Steve Hoffman has been the CEO of the company since 2013. Tyme was acquired by Tyme Technologies, Inc., part of Syros Pharmaceuticals, Inc. from September 19, 2022 on March 05, 2015. | Director/Board Member | 05/05/2015 |
Lautus Pharmaceuticals LLC
 Lautus Pharmaceuticals LLC Household/Personal CareConsumer Non-Durables Lautus Pharmaceuticals LLC engages in the manufacture and sale of cosmetic products. The company was founded in 2013 and is headquartered in Summit, NJ. | Chairman | 01/01/2013 |
Anciens postes connus de Pat LePore
| Sociétés | Poste | Fin |
|---|---|---|
| LANNETT COMPANY, INC. | Chairman | 16/06/2023 |
| MATINAS BIOPHARMA HOLDINGS, INC. | Director/Board Member | 01/11/2021 |
| INNOVIVA, INC. | Director/Board Member | 24/04/2018 |
| PHARMERICA CORPORATION | Director/Board Member | 07/12/2017 |
| ░░░ ░░░░░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
Formation de Pat LePore
| Fairleigh Dickinson University | Masters Business Admin |
| Villanova University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 5 |
|---|---|
| CARDINAL HEALTH, INC. | Distribution Services |
| LANNETT COMPANY, INC. | Health Technology |
| MATINAS BIOPHARMA HOLDINGS, INC. | Health Technology |
| INNOVIVA, INC. | Health Technology |
| VYNE THERAPEUTICS INC. | Health Technology |
| Entreprise privées | 8 |
|---|---|
Endo Generics Holdings, Inc.
 Endo Generics Holdings, Inc. Pharmaceuticals: GenericHealth Technology Endo Generics Holdings, Inc. develops, manufactures, and markets generic pharmaceutical products. It also offers dosage, branded, and generic sterile injectable products. The company was founded in 1978 and is headquartered in New York, NY. | Health Technology |
Boron, LePore & Associates, Inc.
 Boron, LePore & Associates, Inc. Miscellaneous Commercial ServicesCommercial Services Boron, LePore & Associates, Inc. provides integrated medical education to the healthcare industry. It provides strategic consultation, content development, accredited & non-accredited program development, logistics management and other internet-based solutions. The company was founded in 1981 and is headquartered in Wayne, NJ. | Commercial Services |
AgeneBio, Inc.
 AgeneBio, Inc. BiotechnologyHealth Technology AgeneBio, Inc. develops an innovative therapeutics for unserved patients afflicted with neurological and psychiatric diseases to preserve and restore brain function. It research focused on cognitive neuroscience and the neurobiology of the aging brain with most advanced clinical program targets amnestic mild cognitive impairment (aMCI), the symptomatic, pre-dementia stage of Alzheimer’s. The company was founded by Michela Gallagher in 2008 and is headquartered in Baltimore, MD. | Health Technology |
Tyme Technologies, Inc.
 Tyme Technologies, Inc. Pharmaceuticals: MajorHealth Technology Tyme Technologies, Inc. operates as a biotechnology company, which engages in the development and commercialization of cancer therapies. It offers a clinical program named SM-88 which is a novel, oral, and monotherapy investigational agent that aims to disrupt the cancer cell's protein synthesis. The company was founded by Steve Hoffman and Michael Demurjian on November 22, 2011 and is headquartered in Bedminster, NJ. | Health Technology |
Par Pharmaceutical, Inc.
 Par Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Par Pharmaceutical, Inc. manufactures and markets generic drugs and pharmaceuticals products. It produces drugs for hypertension, inflammation, depression and pain. The firm distributes its products in the semi-solid form of a cream. The company was founded in 1978 and is headquartered in Chestnut Ridge, NY. | Health Technology |
PharMerica Corp.
 PharMerica Corp. Drugstore ChainsRetail Trade PharMerica Corp. operates as an institutional pharmacy service company. The firm operates through following segments: Institutional Pharmacy, Specialty Infusion Services, and Specialty Oncology Pharmacy. The company was founded in 2006 and is headquartered in Louisville, KY. | Retail Trade |
Tyme, Inc.
Tyme, Inc. BiotechnologyHealth Technology Part of Syros Pharmaceuticals, Inc., Tyme, Inc. is a private company that provides research and development services focused on developing drug candidates for the treatment of cancer. The company is based in Wilmington, DE. Steve Hoffman has been the CEO of the company since 2013. Tyme was acquired by Tyme Technologies, Inc., part of Syros Pharmaceuticals, Inc. from September 19, 2022 on March 05, 2015. | Health Technology |
Lautus Pharmaceuticals LLC
Lautus Pharmaceuticals LLC Household/Personal CareConsumer Non-Durables Lautus Pharmaceuticals LLC engages in the manufacture and sale of cosmetic products. The company was founded in 2013 and is headquartered in Summit, NJ. | Consumer Non-Durables |
